Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...

HIMS and LFMD are surging in the telehealth race, but which one has stronger earnings growth and expansion momentum? Let's see.

US telehealth company Hims & Hers has reached a deal to buy its UK counterpart Zava in a sign of its ambition to build its European operations, including the supply of weight-loss medicines. The ...

Review the current Hims & Hers Health Inc Ordinary Shares - Class A (HIMS:XNYS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if HIMS is the best ...

Review the current valuation for Hims & Hers Health Inc Ordinary Shares - Class A (HIMS:XNYS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation ...

An ad for compounded versions of weight-loss drug semaglutide by telehealth company Hims & Hers has attracted the ire of a pharmaceutical trade organisation that calls the campaign "nothing short ...

Jun 24, 2025 10:05 AM ET Alerts Market: Open Hims & Hers Health, Inc. Class A Common Stock (HIMS) Bid: $42.90 X 2 Ask: $42.94 X 100 Volume: 19,526,881 ...

Hims & Hers Health Inc. HIMS (U.S.: NYSE) View All companies AT CLOSE 4:00 PM EDT 06/27/25 $ PRE MARKET 7:53 AM EDT 06/30/25 $ PRE MARKET Vol 406,402 Volume 83,385,570 ...

Advanced Charting Compare Compare to Benchmark: DJIA S&P 500 GLOBAL DOW NASDAQ Retail/Wholesale Compare to Open 50.76 Prior Close 49.41 (06/27/25) 1 Day HIMS 0.89% DJIA 0.63% S&P 500 0.52% Retail ...